AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Saving cash on a tight budget is possible with the right strategies. Discover effective tips to stretch your dollars further.
22,187 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
delek holdings rallied today captured market attention as a mid-cap refiner with jet-fuel exposure and a strategic st...
Volatility in markets remains elevated, and two monthly dividend ETFs built for lower volatility are drawing attentio...
Two sector income ETFs are delivering yields well above the S&P 500 as investors price in a possible recession. The g...
Airbnb’s latest quarterly results reinforce that airbnb’s billion growth story is far from peaking, underscored by ro...
Two AI security stalwarts are racing for the top spot in the cyber defense era. This guide breaks down CrowdStrike vs...
Berkshire Hathaway's big Alphabet stake marks a rare foray into technology by Warren Buffett. This article breaks dow...
AppLovin reported its best quarter in history, with record revenue and an 84% EBITDA margin, but the stock declined s...
Investors chase the next big tech story, and quantum computing stocks are no exception. This guide explains what tend...
A single, powerful driver could unlock a dramatic March for Netflix. Learn the core monetization lever and what inves...
As 2026 unfolds, AT&T and Verizon compete for income and growth. This analysis weighs dividend safety, leverage, and ...
A leading fintech player reveals a real-world crypto use case that could reshape how merchants and consumers transact...